Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SOHAM PHARMALikely | 1 | ₹3,742.20 |
| 2 | Schedule 2 | SOHAM PHARMALikely | 2 | ₹7,900.20 |
| 3 | Schedule 3 | MEDIKON INDIA PRIVATE LIMITEDLikely | 2 | ₹34,650 |
| 4 | Schedule 4 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITEDLikely | 3 | ₹303 |
| 5 | Schedule 5 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITEDLikely | 3 | ₹2,730 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
4 May 2026, 4:00 pmClosed
ECHS CFA RE 01
9251447
GEM/2026/B/7469952
Two Packet Bid
CAP CALCITRIOL 0 POINT 25 MCG,TAB PYRIDOSTIGMINE SR 180 MG,INJ TIRZEPATIDE 10 MG 0 POINT 6 ML PFS O
Central Delhi, Delhi
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
10%
Exempted
Yes
4 May 2026
23 Apr 2026
4 May 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | CAP CALCITRIOL 0 POINT 25 MCG | 540 | No | Central Delhi | 15 | |
| 2 | TAB PYRIDOSTIGMINE SR 180 MG | 180 | No | Central Delhi | 15 | |
| 3 | INJ TIRZEPATIDE 10 MG 0 POINT 6 ML PFS OF 2 POINT 4 ML | 2 | PFS | Central Delhi | 15 | |
| 4 | INJ ZOLEDRONIC ACID 4 MG | 3 | No | Central Delhi | 15 | |
| 5 | INJ LEUPROLIDE ACID 3 POINT 75 MG | 3 | Vial | Central Delhi | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9251447.pdf
GEM_BID • 0.11 MB
specification_cfa_re-01_2026-04-23-15-44-46_b2cc2317259f10164fcfed2097367f75.pdf
BOQ • 0.20 MB
boq_item_sample_file_2026-04-23-15-44-46_f02643394fc9de10638dd15331aa74dc.csv
BOQ • 0.00 MB
GEM_OTHER • 1.82 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .